Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Australia
45 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Southport, Waratah
- Age
- 18 years to 75 years
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Bedford Park, Melbourne, New Lambton Heights, Orange, Randwick
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Clayton
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - Phase 3Not yet taking people in AustraliaFutibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer
- Where
- Brisbane, Melbourne, Perth, Sydney
- Age
- 18 years and over
- People
- 784 worldwide
- Run by
- Taiho Pharmaceutical Co., Ltd.
See details and how to joinNCT07710885 - No phaseTaking peopleA Study of Standard Of Care Versus Radio Ablation in Early Stage HCC
- Where
- Waratah
- Age
- 18 years and over
- People
- 218 worldwide
- Run by
- University Health Network, Toronto
See details and how to joinNCT07628751 - Phase 1Taking peopleA Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
- Where
- Adelaide, Ryde, Sydney, Westmead
- Age
- 18 years and over
- People
- 36
- Run by
- EtiraRx Australia Pty Ltd
See details and how to joinNCT06533332 - Phase 1Taking peopleSafety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
- Where
- Adelaide, Darlinghurst, Melbourne, Nedlands, Randwick, South Brisbane, Waratah
- Age
- 18 years and over
- People
- 60
- Run by
- Myeloid Therapeutics
See details and how to joinNCT07334119 - No phaseTaking peopleRadio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
- Where
- Melbourne, Waratah, Westmead, Woolloongabba
- Age
- 18 years and over
- People
- 50
- Run by
- University of Sydney
See details and how to joinNCT05169177 - No phaseTaking peopleLEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Where
- Melbourne, Saint Leonards, Woolloongabba
- Age
- 18 years and over
- People
- 300
- Run by
- University of Sydney
See details and how to joinNCT05184790 - Phase 2Taking peoplePhase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)
- Where
- Bedford Park, Camperdown, Clayton, Melbourne, St Leonards, Westmead, Wollongong, Woolloongabba
- Age
- 18 years and over
- People
- 40
- Run by
- Australasian Gastro-Intestinal Trials Group
See details and how to joinNCT06441747 - No phaseNot yet taking people in AustraliaThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Melbourne
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 1Taking peopleSapu003 in Advanced mTOR-sensitive Solid Tumors
- Where
- Adelaide
- Age
- 18 years and over
- People
- 27
- Run by
- SAPU NANO (US) LLC
See details and how to joinNCT07369505 - Phase 4Taking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Southport
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - Phase 1Taking peopleA Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
- Where
- Melbourne, Murdoch, Sydney, Woolloongabba
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Myeloid Therapeutics
See details and how to joinNCT06478693 - No phaseNot yet taking people in AustraliaLTFU for All Cell and Gene Therapy Studies
- Where
- East Melbourne
- Age
- 18 years to 130 years
- People
- 64 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06194461 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Parkville
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseNot yet taking people in AustraliaThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Melbourne
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - No phaseTaking peopleThe DRAGON 2 Trial
- Where
- Clayton
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Maastricht University
See details and how to joinNCT05428735 - No phaseTaking peopleHCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
- Where
- Brisbane, Camperdown, Concord, Fitzroy, Gosford, Heidelberg, Perth, Randwick, Westmead
- Age
- 20 years to 85 years
- People
- 476 worldwide
- Run by
- Concord Repatriation General Hospital
See details and how to joinNCT04455932